Dependence is a  key concern around esketamine treatment. Urging caution and a need for public debate, a British expert observed that “we need to not let the genie get out of the bottle”

A new drug for treating depression has been approved in the US by the Federal Drug Administration (FDA). The same drug is now undergoing evaluation by(...)